Merck, University of Texas MD Anderson Cancer Center deal

Merck and MD Anderson partnered to study Keytruda in combination with chemotherapy, radiation therapy and undisclosed antitumor medicines from Merck in gastroesophageal adenocarcinoma, pancreatic ade...